Anti-epileptic drugs do not increase suicidality in epilepsy patients, study finds
This article was originally published in Scrip
The use of anti-epileptic drugs in patients with epilepsy who do not have a psychiatric illness may not be associated with an increased risk of suicidality, a study published in the New England Journal of Medicine has suggested.
You may also be interested in...
Somaxon Pharmaceuticals and Procter & Gamble Pharmaceuticals are to co-promote Somaxon's insomnia drug Silenor (low-dose doxepin) in the US.
GlaxoSmithKline has begun the Phase III clinical trials programme for its adjuvanted vaccine candidate (GSK1437173A) against herpes zoster for the prevention of shingles.
The EMA has accepted Optimer Pharmaceuticals' MAA for its narrow-spectrum antibiotic fidaxomicin for the treatment of Clostridium difficile infection (CDI) and for the prevention of recurrences of CDI.